rectal cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. High-moderately differentiated rectal adenocarcinoma confirmed by electronic colonoscopy and histopathological examination before operation; 2. Aged 18-75 years; 3. The size of the tumor < 1/3 the circumference of the bowel; 4. The cancer is located in the lower 1/3 of the rectum (2-5cm from the anal verge); 5. Preoperative pelvic rectal sequence MRI examination, the tumor is in T1-T2 stage, and it is not suitable for local resection through anus; 6. No distant metastasis in preoperative examination; 7. No history of gastrointestinal surgery; 8. Anal function is normal; 9. The enrolled patients underwent robotic-assisted or laparoscopic-assisted radical rectal resection (ISR); 10. The patient has good compliance and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Poor tumor differentiation; 2. Received neoadjuvant therapy before surgery, including radiotherapy and chemotherapy; 3. Patients with acute abdomen such as acute intestinal obstruction and intestinal perforation; 4. History of rectal or anal surgery in the past; 5. Patients with tumors in other parts; 6. Combined with severe cardiopulmonary diseases, etc., unable to tolerate anesthesia and surgery; 7. Patients with combined mental illness; 8. Combined pregnancy patients; 9. Other patients deemed unsuitable for inclusion by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Kelly Scale;QLQ-C30 Quality of Life Score; | — |
Countries
China